1-(4-nitrophenyl)-9H-β-carboline-3-carboxylic acid | 942217-37-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-(4-nitrophenyl)-9H-β-carboline-3-carboxylic acid
• 英文别名: 1-(4-nitrophenyl)-9H-pyrido[3,4-b]indole-3-carboxylic acid
• CAS: 942217-37-0
• 化学式: C₁₈H₁₁N₃O₄
• 分子量: 333.303
• InChiKey: JHMUQEUYKZGDCI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  25
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  112
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(4-nitrophenyl)-9H-β-carboline-3-carboxylic acid 在 硫酸 、 一水合肼 作用下， 以 乙醇 为溶剂， 反应 78.0h， 生成 N'-cyclopentylidene-1-(4-nitrophenyl)-β-carboline-3-carbohydrazide
  参考文献：
  名称：

  β-咔啉3-（取代-咔唑）衍生物的合成及抗肿瘤活性

  摘要：

  合成了一系列在C-3处带有取代的碳酰肼部分的β-咔啉衍生物，并评估了其对八种人类癌细胞系的抗肿瘤活性。通常，β-咔啉N-（取代的亚苄基）碳酰肼显示出比其N-（亚烷基）碳酰肼类似物更大的抗肿瘤活性。β-咔啉N-（取代的亚苄基）碳酰肼的N 9甲基化导致抗肿瘤活性降低。在所测试的化合物中，苄基碳酰肼3，4，11，13，16，21和22是最活跃的，具有IC对于八种肿瘤细胞系中的六种，有50种小于10μM。衍生物4对所有测试的细胞系表现出最显着的活性，对肾脏（786-0）细胞系具有显着的细胞毒性（IC 50  = 0.04μM）。在Ehrlich实体癌测定中测定化合物4的体内抗肿瘤活性。

  DOI：

  10.1016/j.bmc.2011.08.059
• 作为产物：
  描述：

  methyl (3S)-1-(4-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate 在 potassium permanganate 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 生成 1-(4-nitrophenyl)-9H-β-carboline-3-carboxylic acid
  参考文献：
  名称：

  Synthesis and Fungicidal Activity of β-Carboline Alkaloids and Their Derivatives

  摘要：

  本研究设计、合成并评估了一系列β-吲哚衍生物的杀菌活性。几个衍生物表现出对某些真菌的选择性杀菌活性。特别是，化合物F5对根腐病菌（Rhizoctonia solani）的杀菌活性（53.35%）高于商业抗病毒药物惟克（validamycin）的活性（36.4%）；化合物F16对柑橘糠病菌（Oospora citriaurantii ex Persoon）的杀菌活性较高（43.28%）。一些生物碱及其衍生物（化合物F4和F25）表现出广谱的杀菌活性。具体来说，化合物F4在体外表现出优异的广谱杀菌活性，对荔枝病（P. litchi）的治愈和保护活性分别达到92.59%和59.26%。新衍生物F4具有优化的物理化学性质，明显在体内外展现出更高的活性；因此，F4可能作为新型杀菌药物研发的领先结构。

  DOI：

  10.3390/molecules200813941

文献信息

• Dehydrogenation of 1-aryl(hetaryl)-1,2,3,4-tetrahydro-9H-β-carboline-3-carboxylic acids and their esters with dimethyl sulfoxide
  作者：M. G. Abramyants、D. A. Lomov、T. I. Zavyazkina

  DOI：10.1134/s1070428016110117

  日期：2016.11

  boline-3-carboxylic acids derivatives with dimethyl sulfoxide leads to the formation of 1-aryl(hetaryl)-9Н-β-carbolines. Simultaneously with the dehydrogenation decarboxylation occurs. At the oxidation with dimethyl sulfoxide of methyl 1-aryl (hetaryl)-1,2,3,4-tetrahydro-9Н-β-carboline-3-carboxylicates methyl 1-aryl(hetaryl)-9Н-β-carboline-3-carboxylates formed whose hydrolysis afforded the corresponding

  1-芳基（杂芳基）-1,2,3,4-四氢-9-氧化脱氢Н -β-β-咔啉-3-羧酸的衍生物与二甲亚砜通向1-芳基（杂芳基）-9形成Н - β-咔啉。与脱氢同时发生脱羧。在用甲基1-芳的二甲亚砜（杂芳基）-1,2,3,4-四氢-9-氧化Н -β-β-咔啉-3- carboxylicates甲基-1-芳基（杂芳基）-9- Н -β咔啉形成3-羧酸盐，其水解得到相应的1-芳基（杂芳基）-9Н -β-咔啉-3-羧酸。
• Synthesis, Antileishmanial Activity and Spin Labeling EPR Studies of Novel β-Carboline-Oxazoline and β-Carboline-Dihydrooxazine Derivatives
  作者：Paula Baréa、Jéssica de Paula、Laís Alonso、Aline de Oliveira、Willian da Costa、Antonio Alonso、Celso Nakamura、Maria Sarragiotto

  DOI：10.21577/0103-5053.20200003

  日期：——

  A series of novel 1-(substituted-phenyl)-3-(4,5-dihydro-1,3-oxazol-2-yl)-9H-beta-carboline (8a-8i) and 1-(substituted-phenyl)-3-(5,6-dihydro-4H-1,3-oxazin-2-yl)-9H-beta-carboline (9a-9h) derivatives. as well as their respective N-(chloroalkyl)-1-(substituted-phenyl)-9H-beta-carboline-3-carboxamide precursors (6a-6i and 7a-7h), were synthesized and evaluated for their in vitro antileishmanial activity against promastigote and intracellular amastigote forms of Leishmania amazonensis. Compounds 8d. 8i, 9e and 9h exhibited significant activity for both promastigote and amastigote forms, with IC50 (50% inhibitory concentration) values ranging from 2.9 to 23.0 mu M. In addition, spin label electron paramagnetic resonance (EPR) spectroscopy studies were carried out for the most active compounds against L amazonensis promastigotes. The studies indicated that the tested compounds cause strong stiffness in the parasite plasma membrane and are capable of inducing internal metalloproteins oxidation of the parasite, resulting in their cross-linking to skeletal proteins. Compounds 8d and 8i produced the largest effect, showing that the presence of oxazoline group at C-3 of beta-carboline nucleus is important for antileishmanial activity.
• [EN] SMALL MOLECULE INHIBITORS OF THE CRL4 UBIQUITIN LIGASE<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE L'UBIQUITINE LIGASE CRL4
  申请人：[en]CORNELL UNIVERSITY

  公开号：WO2023173136A2

  公开（公告）日：2023-09-14

  Compounds of formula (I), compounds of formula (II), and compounds of formula (III) are disclosed. Also disclosed are compounds, compositions, and methods to inhibit CUL4A expression or activity, CUL4B expression or activity, and/or DDB1 expression or activity for the treatment or prevention of cancer, DNA damage, or related conditions. In some aspects, the interaction between CUL4A and/or CUL4B and the beta-propeller B of DDB1 is disrupted with the compounds, compositions, or methods.